SMi proudly presents its 12th annual Pain Therapeutics conference, which will be held on 21st & 22nd May 2012 in London.
Pain is the most common reason patients seek medical care and has significant sensory and emotional components. Despite the advances in pain management, few significant advancements have been made, and in recent years it has become harder and harder to get analgesics to market.
With the whole industry under financial pressure, there is an economic imperative for companies to improve their research and development methods in order to ensure that drugs being put forward for clinical trials have the best chance of success.
Pain Therapeutics 2012 will allow delegates to hear from industry experts discussing the latest advances in drug development practice and analysing recent case studies of where drugs in the clinical stages have succeeded and failed. This must-attend event will also take an in-depth look at the recent work on current drug targets such as the TRPV famil
